Corticosteroids and cognitive function in humans: methodological considerations.
Loring
D W
DW
Medical College of Georgia, Department of Neurology, Augusta 30912, USA.
Meador
K J
KJ
D000818:Animals; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000633:toxicity; D015982:Bias; D002648:Child; D002986:Clinical Trials as Topic / Q000379:methods; D003072:Cognition Disorders / Q000139:chemically induced* / Q000209:etiology; D003710:Demography; D003907:Dexamethasone / Q000009:adverse effects* / Q000633:toxicity; D004311:Double-Blind Method; D004521:Educational Measurement; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007858:Learning / Q000187:drug effects; D007859:Learning Disabilities / Q000139:chemically induced / Q000209:etiology; D008568:Memory / Q000187:drug effects; D008569:Memory Disorders / Q000139:chemically induced / Q000209:etiology; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D011987:Receptors, Steroid / Q000378:metabolism; D012107:Research Design; D012189:Retrospective Studies; D013312:Stress, Physiological / Q000378:metabolism / Q000523:psychology
D018931:Antineoplastic Agents, Hormonal; D011987:Receptors, Steroid; D003907:Dexamethasone